SCHEMBL10076136

SCHEMBL10076136

CC[C@H](N)C(=O)NC(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP9 Q86TI2 8/20 0.50
DPP4 P27487 7/20 0.50
DPP8 Q6V1X1 7/20 0.50
DPP7 Q9UHL4 6/20 0.50
CTSC P53634 5/20 0.42
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CTSH P09668 1/20 0.39
CYP2D6 P10635 1/20 0.39
CTSK P43235 1/20 0.39
SLC15A1 P46059 1/20 0.38
MEN1 O00255 1/20 0.38
FAAH O00519 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
EPHX1 P07099 2/20 0.36
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16999949 1.00 DPP9 (0.50) DPP9DPP4DPP8DPP7CTSC
SCHEMBL13829067 0.82 DPP7 (0.56) DPP9DPP4DPP8DPP7SLC15A1
SCHEMBL23866587 0.81 DPP4 (0.39) DPP9DPP4DPP8DPP7SLC15A1
SCHEMBL20649207 0.81 DPP4 (0.39) DPP9DPP4DPP8DPP7SLC15A1
SCHEMBL24221417 0.81 DPP9 (0.49) DPP9DPP4DPP8DPP7ALDH1A1
SCHEMBL12269108 0.81 DPP4 (0.39) DPP9DPP4DPP8DPP7SLC15A1
SCHEMBL17868351 0.80 MME (0.56) DPP9DPP4DPP8DPP7CTSC
SCHEMBL21748461 0.80 MME (0.56) DPP9DPP4DPP8DPP7CTSC
SCHEMBL19502439 0.80 DPP4 (0.46) DPP9DPP4DPP8DPP7CTSC
SCHEMBL21034312 0.79 PTGS1 (0.46) DPP9DPP4DPP8DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES MTAP, TYMP, PHOSPHO1 DPP9 187/4885DPP4 53/4885DPP8 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.